<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39465803</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>41</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>11</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Is detrusor underactivity the urodynamic characteristic of long-COVID in patients with benign prostate hyperplasia?</ArticleTitle><Pagination><StartPage>e40156</StartPage><MedlinePgn>e40156</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e40156</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000040156</ELocationID><Abstract><AbstractText>Although coronavirus disease 19 (COVID-19) was reported to involve with multiple organs, COVID-19 reports focusing on urinary system mostly evaluated the association between lower urinary tract symptoms and COVID-19 using questionnaire score. In this study, sonography video urodynamic studies was first conducted to explore the effects of COVID-19 on contractility of bladder detrusor of patients with benign prostate hyperplasia (BPH). Clinical data was respectively reviewed and compared between BPH patients with previous COVID-19 infection (COVID-19 group) and without previous COVID-19 (non-COVID-19 group). The incidence of detrusor underactivity (DU) was compared between 2 groups. Comparison of age and noninvasive parameters was conducted between BPH patients with DU and without DU in COVID-19 group. Correlation coefficient between noninvasive parameters and detrusor contractility was determined and receiver operating characteristic curve of noninvasive parameters was used to choose the most appropriate cutoff for detection of DU in COVID-19 group. Beside a significant increase in the incidence of DU in BPH patients of COVID-19 group, a lower detrusor contractility and a greater bladder wall thick was detected compared to that of patients in non-COVID-19 group. Post-voiding residual urine was found to have a linear correlation with detrusor contractility in COVID-19 group. It was suggested that COVID-19 infection would further exacerbate impairment of detrusor previously resulted from bladder outlet obstruction in BPH patients. DU may be a urodynamic characteristic of long-COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Ning</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-4842-0456</Identifier><AffiliationInfo><Affiliation>Department of Urology, Video Urodynamic Studies Center, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, Continence Research Clinic, Shaoyang Central Hospital, Shaoyang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, Shaoyang Hosptial Affiliated to University of South China, Shaoyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Jinhua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Trauma, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Urology, Video Urodynamic Studies Center, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Gaoyu</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Urology, Video Urodynamic Studies Center, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Kailu</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Urology, Video Urodynamic Studies Center, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Huasheng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Urology, Continence Research Clinic, Shaoyang Central Hospital, Shaoyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jianfeng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Urology, Continence Research Clinic, Shaoyang Central Hospital, Shaoyang, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2021SK52002</GrantID><Agency>Planned projects of Guiding technological innovation of Hunan Province</Agency><Country/></Grant><Grant><GrantID>20210218-2</GrantID><Agency>Guilin Science and Technology Development Program</Agency><Country/></Grant><Grant><GrantID>S2020105</GrantID><Agency>Scientific Research Project of Guangxi Health Commission</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011470" MajorTopicYN="Y">Prostatic Hyperplasia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014563" MajorTopicYN="Y">Urodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077295" MajorTopicYN="Y">Urinary Bladder, Underactive</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="Y">Ultrasonography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001743" MajorTopicYN="N">Urinary Bladder</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>12</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>8</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39465803</ArticleId><ArticleId IdType="pmc">PMC11479469</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000040156</ArticleId><ArticleId IdType="pii">00005792-202410110-00021</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guo YR, Cao QD, Hong ZS, et al. . The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7068984</ArticleId><ArticleId IdType="pubmed">32169119</ArticleId></ArticleIdList></Reference><Reference><Citation>Talaat M, Abdelbaky TM, Marand AJB, et al. . Lower urinary tract signs and symptoms in patients with COVID-19. Low Urin Tract Symptoms. 2021;21:706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8661677</ArticleId><ArticleId IdType="pubmed">34435456</ArticleId></ArticleIdList></Reference><Reference><Citation>Karabulut I, Cinislioglu AE, Cinislioglu N, et al. . The effect of the presence of lower urinary system symptoms on the prognosis of COVID-19: preliminary results of a prospective study. Urol Int. 2020;104:853&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7573898</ArticleId><ArticleId IdType="pubmed">32894859</ArticleId></ArticleIdList></Reference><Reference><Citation>Balawender K, Pliszka A, Krowiak A, Sito M, Grabarek BO, Boro&#x144; D. Does SARS-CoV-2 affect male urogenital system? Curr Pharm Biotechnol. 2022;23:1792&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">35255789</ArticleId></ArticleIdList></Reference><Reference><Citation>Mumm JN, Osterman A, Ruzicka M, et al. . Urinary frequency as a possibly overlooked symptom in COVID-19 Patients: does SARS-CoV-2 Cause Viral Cystitis? Eur Urol. 2020;78:624&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236674</ArticleId><ArticleId IdType="pubmed">32475747</ArticleId></ArticleIdList></Reference><Reference><Citation>Can O, Erko&#xe7; M, Ozer M, Karakanli MU, Otunctemur A. The effect of COVID-19 on lower urinary tract symptoms in elderly men. Int J Clin Pract. 2021;75:e14110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7995211</ArticleId><ArticleId IdType="pubmed">33621391</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabeeh H, Ibrahim A, Taha DE. Impact of COVID-19 pandemic on lower urinary tract symptoms in patients with benign prostatic hyperplasia and predictors of urine retention in such patients. Low Urin Tract Symptoms. 2022;14:41&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8661677</ArticleId><ArticleId IdType="pubmed">34435456</ArticleId></ArticleIdList></Reference><Reference><Citation>Farah S, Miranne JM, Dhawan A, Ganduboina R. COVID-associated cystitis: the culprit behind the bladder woes post-COVID infection? A review. Low Urin Tract Symptoms. 2023;55:2367&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">37410305</ArticleId></ArticleIdList></Reference><Reference><Citation>Fusco F, Mirone V, Sagnelli E, et al. . COVID-19 inflammation results in urine cytokine elevation and causes COVID-19 associated cystitis (CAC). J Med Virol. 2020;145:110375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7644255</ArticleId><ArticleId IdType="pubmed">33213997</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki T, Tominaga K, Okabe YU, et al. . Exacerbation of urinary storage symptoms by the psychological stress induced by the COVID-19 Pandemic. In vivo (Athens, Greece). 2022;36:2800&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9677762</ArticleId><ArticleId IdType="pubmed">36309381</ArticleId></ArticleIdList></Reference><Reference><Citation>Enikeev D, Misrai V, Rijo E, et al. . EAU, AUA and NICE guidelines on surgical and minimally invasive treatment of benign prostate hyperplasia: a critical appraisal of the guidelines using the AGREE-II Tool. Urol Int. 2022;106:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">34350885</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard L, Braschi E, Averbeck MA, Creta M, Sagnelli C. SARS-CoV-2 infection affects the lower urinary tract and male genital system: a systematic review. Neurourol Urodyn. 2021;93:3133&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013185</ArticleId><ArticleId IdType="pubmed">33595134</ArticleId></ArticleIdList></Reference><Reference><Citation>Vredeveld T, van Benten E, Beekmans REPM, et al. . Reliability and validity of assessment methods available in primary care for bladder outlet obstruction and benign prostatic obstruction in men with lower urinary tract symptoms: a systematic review. BMJ open. 2022;12:e056234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9058800</ArticleId><ArticleId IdType="pubmed">35487713</ArticleId></ArticleIdList></Reference><Reference><Citation>Sevim M, Alki&#x15f; O, Kartal IG, Co&#x15f;er S, Akman H, Aras B. Impact of COVID-19 on the progression of benign prostatic hyperplasia and aggravation of related symptoms: a prospective study. Prostate. 2023;83:82&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9538060</ArticleId><ArticleId IdType="pubmed">36073724</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvi I, D&#xf6;nmez MI, Ziylan O, Oktar T. Urodynamically proven lower urinary tract dysfunction in children after COVID-19: a case series. Low Urin Tract Symptoms. 2022;14:301&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115155</ArticleId><ArticleId IdType="pubmed">35293147</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuen JS, Ngiap JT, Cheng CW, Foo KT. Effects of bladder volume on transabdominal ultrasound measurements of intravesical prostatic protrusion and volume. Int J Urol. 2002;9:225&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12010318</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoag N, Gani J. Underactive bladder: clinical features, urodynamic parameters, and treatment. Int Neurourol J. 2015;19:185&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4582091</ArticleId><ArticleId IdType="pubmed">26620901</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosier P, Schaefer W, Lose G, et al. . International continence society good urodynamic practices and terms 2016: urodynamics, uroflowmetry, cystometry, and pressure-flow study. Neurourol Urodyn. 2017;36:1243&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">27917521</ArticleId></ArticleIdList></Reference><Reference><Citation>Dornbier R, Pahouja G, Branch J, McVary KT. The New American urological association benign prostatic hyperplasia clinical guidelines: 2019 Update. Curr Urol Rep. 2020;21:32.</Citation><ArticleIdList><ArticleId IdType="pubmed">32607874</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanov A, Antonov P, Hristova-Atanasova E, Uchikov P. Changes in lower urinary tract symptoms in benign prostatic hyperplasia patients affected by Covid-19. Urol Int. 2023;107:358&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9981776</ArticleId><ArticleId IdType="pubmed">36807219</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerner LB, McVary KT, Barry MJ, et al. . Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management. J Urol. 2021;206:806&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">34384237</ArticleId></ArticleIdList></Reference><Reference><Citation>Jhang JF, Jiang YH, Hsu YH, Ho HC, Kuo HC. Pathogenesis evidence from human and animal models of detrusor underactivity. Tzu chi Med J. 2022;34:287&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9333099</ArticleId><ArticleId IdType="pubmed">35912048</ArticleId></ArticleIdList></Reference><Reference><Citation>Wittenberg S, Vercnocke J, Chancellor M, et al. . Prolonged impacts of COVID-19-associated cystitis: a study on long-term consequences. World J Clin Cases. 2023;11:7987&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10698398</ArticleId><ArticleId IdType="pubmed">38075566</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamb LE, Dhar N, Timar R, et al. . COVID-19 inflammation results in urine cytokine elevation and causes COVID-19 associated cystitis (CAC). Int Urol Nephrol. 2020;145:110375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7644255</ArticleId><ArticleId IdType="pubmed">33213997</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi R, Takei M, Namitome R, Yamaguchi O, Eto M. Symptoms and noninvasive test parameters that clinically differentiate detrusor underactivity from bladder outlet obstruction without a pressure-flow-based diagnosis in men with lower urinary tract symptoms. Neurourol Urodyn. 2021;40:303&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">33118659</ArticleId></ArticleIdList></Reference><Reference><Citation>Yono M, Ito K, Oyama M, Tanaka T, Irie S, Matsukawa Y. Variability of post-void residual urine volume and bladder voiding efficiency in patients with underactive bladder. Low Urin Tract Symptoms. 2021;13:51&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">32525267</ArticleId></ArticleIdList></Reference><Reference><Citation>Namitome R, Takei M, Takahashi R, et al. . A prediction model of detrusor underactivity based on symptoms and noninvasive test parameters in men with lower urinary tract symptoms: an analysis of a large group of patients undergoing pressure-flow studies. J Urol. 2020;203:779&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">31647388</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>